Get the full picture
Sign in to uncover key details.
Show More
Oncolytics Biotech
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4350 Executive Dr Ste 325, San Diego, Ca...Phone Number
(403) 670-7377Website
www.oncolyticsbiotech.comRevenue
$26.1 MillionStock Symbol
ONCYIndustry
About Oncolytics Biotech
Oncolytics Biotech Inc, a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing REOLYSIN, an immuno-oncology viral-agent that comprises three programs: chemotherapy combinations to trigger selective tumor lysis; immune modulator combinations to facilitate innate immune responses; and immuno-therapy combinations to produce adaptive immune responses. The company was founded in 1998 and is based out of Alberta, Canada.Explore more
Oncolytics Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Oncolytics Biotech
Compare insights from companies similar to Oncolytics Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Oncolytics Biotech Tech Stack
A closer look at the technologies used by Oncolytics Biotech
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Oncolytics Biotech
Sign Up For FreeTo access detailed company insights
Oncolytics Biotech Inc, a development stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing REOLYSIN, an immuno-oncology viral-agent that comprises three programs: chemotherapy combinations to trigger selective tumor lysis; immune modulator combina... Read More
